• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

查加辛是克氏锥虫的内源性半胱氨酸蛋白酶抑制剂,可调节寄生虫的分化以及对哺乳动物细胞的侵袭。

Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.

作者信息

Santos Camila C, Sant'anna Celso, Terres Amanda, Cunha-e-Silva Narcisa L, Scharfstein Julio, de A Lima Ana Paula C

机构信息

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, C.C.S., Ilha do Fundão, Rio de Janeiro, 21949-900 RJ, Brazil.

出版信息

J Cell Sci. 2005 Mar 1;118(Pt 5):901-15. doi: 10.1242/jcs.01677. Epub 2005 Feb 15.

DOI:10.1242/jcs.01677
PMID:15713748
Abstract

Chagasin is a Trypanosoma cruzi protein that was recently characterized as a tight-binding inhibitor of papain-like cysteine proteases (CPs). Considering that parasite virulence and morphogenesis depend on the endogenous activity of lysosomal CPs of the cruzipain family, we sought to determine whether chagasin and cruzipain interact in the living cell. Ultrastructural studies showed that chagasin and cruzipain both localize to the Golgi complex and reservosomes (lysosome-like organelles), whereas free chagasin was found in small intracellular vesicles, suggesting that chagasin trafficking pathways might intersect with those of cruzipain. Taking advantage of the fact that sodium dodecyl sulphate and beta-mercaptoethanol prevent binding between the isolated proteins but do not dismantle preformed cruzipain-chagasin complexes, we obtained direct evidence that chagasin-cruzipain complexes are indeed formed in epimastigotes. Chagasin transfectants (fourfold increase in CP inhibitory activity) displayed low rates of differentiation (metacyclogenesis) and exhibited increased resistance to a synthetic CP inhibitor. These phenotypic changes were accompanied by a drastic reduction of soluble cruzipain activity and by upregulated secretion of cruzipain-chagasin molecular complexes. Analysis of six T. cruzi strains revealed that expression levels of cruzipain and chagasin are variable, but the molar ratios are fairly stable ( approximately 50:1) in most strains, with the exception of the G strain (5:1), which is poorly infective. On the same vein, we found that trypomastigotes overexpressing chagasin are less infective than wild-type parasites in vitro. The deficiency of chagasin overexpressers is caused by lower activity of membrane-associated CPs, because membranes recovered from wild-type trypomastigotes restored infectivity and this effect was nullified by the CP inhibitor E-64. In summary, our studies suggest that chagasin regulates the endogenous activity of CP, thus indirectly modulating proteolytic functions that are essential for parasite differentiation and invasion of mammalian cells.

摘要

查加辛是一种克氏锥虫蛋白,最近被鉴定为木瓜蛋白酶样半胱氨酸蛋白酶(CPs)的紧密结合抑制剂。鉴于寄生虫的毒力和形态发生依赖于克鲁兹蛋白酶家族溶酶体CPs的内源性活性,我们试图确定查加辛和克鲁兹蛋白酶在活细胞中是否相互作用。超微结构研究表明,查加辛和克鲁兹蛋白酶都定位于高尔基体复合体和贮存体(类溶酶体细胞器),而游离的查加辛存在于小的细胞内囊泡中,这表明查加辛的运输途径可能与克鲁兹蛋白酶的运输途径相交。利用十二烷基硫酸钠和β-巯基乙醇可阻止分离蛋白之间的结合但不会破坏预先形成的克鲁兹蛋白酶-查加辛复合物这一事实,我们获得了直接证据,证明查加辛-克鲁兹蛋白酶复合物确实在无鞭毛体中形成。查加辛转染子(CP抑制活性增加四倍)表现出低分化率(循环后期发育),并对合成CP抑制剂表现出增强的抗性。这些表型变化伴随着可溶性克鲁兹蛋白酶活性的急剧降低以及克鲁兹蛋白酶-查加辛分子复合物分泌的上调。对六种克氏锥虫菌株的分析表明,克鲁兹蛋白酶和查加辛的表达水平是可变的,但在大多数菌株中摩尔比相当稳定(约50:1),除了感染性较差的G菌株(5:1)。同样,我们发现体外过表达查加辛的锥鞭毛体比野生型寄生虫的感染性更低。查加辛过表达菌株的缺陷是由膜相关CPs的活性降低引起的,因为从野生型锥鞭毛体回收的膜恢复了感染性,并且这种作用被CP抑制剂E-64消除。总之,我们的研究表明,查加辛调节CP的内源性活性,从而间接调节对寄生虫分化和入侵哺乳动物细胞至关重要的蛋白水解功能。

相似文献

1
Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.查加辛是克氏锥虫的内源性半胱氨酸蛋白酶抑制剂,可调节寄生虫的分化以及对哺乳动物细胞的侵袭。
J Cell Sci. 2005 Mar 1;118(Pt 5):901-15. doi: 10.1242/jcs.01677. Epub 2005 Feb 15.
2
Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi.克氏锥虫中紧密结合的半胱氨酸蛋白酶抑制剂查加辛的鉴定、特性分析及定位
J Cell Sci. 2001 Nov;114(Pt 21):3933-42. doi: 10.1242/jcs.114.21.3933.
3
Solution structure and backbone dynamics of the Trypanosoma cruzi cysteine protease inhibitor chagasin.克氏锥虫半胱氨酸蛋白酶抑制剂查加辛的溶液结构与主链动力学
J Mol Biol. 2006 Apr 14;357(5):1511-21. doi: 10.1016/j.jmb.2006.01.064. Epub 2006 Feb 3.
4
Crystal structure of the parasite inhibitor chagasin in complex with papain allows identification of structural requirements for broad reactivity and specificity determinants for target proteases.寄生虫抑制剂查加辛与木瓜蛋白酶复合物的晶体结构有助于确定其广泛反应性的结构要求以及靶蛋白酶的特异性决定因素。
FEBS J. 2009 Feb;276(3):793-806. doi: 10.1111/j.1742-4658.2008.06824.x.
5
Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion.克氏锥虫入侵期间,克氏锥虫蛋白酶激活宿主细胞中的潜伏转化生长因子-β 。
PLoS One. 2015 May 4;10(5):e0124832. doi: 10.1371/journal.pone.0124832. eCollection 2015.
6
Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi.天然存在的蛋白酶抑制剂在克氏锥虫对宿主细胞信号传导和细胞侵袭的调节中的作用。
Subcell Biochem. 2008;47:140-54. doi: 10.1007/978-0-387-78267-6_11.
7
Crystal structure of chagasin, the endogenous cysteine-protease inhibitor from Trypanosoma cruzi.恰加斯因(来自克氏锥虫的内源性半胱氨酸蛋白酶抑制剂)的晶体结构。
J Struct Biol. 2007 Feb;157(2):416-23. doi: 10.1016/j.jsb.2006.07.017. Epub 2006 Aug 17.
8
In Silico Analysis of Homologous Heterodimers of Cruzipain-Chagasin from Structural Models Built by Homology.基于同源建模构建的克氏锥虫 cruzipain-chagasin 同源异二聚体的计算分析。
Int J Mol Sci. 2019 Mar 15;20(6):1320. doi: 10.3390/ijms20061320.
9
Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.来自克氏锥虫的半胱氨酸蛋白酶同工型,即克氏锥虫蛋白酶2和克氏锥虫蛋白酶,对底物具有不同的偏好性,并且对抑制剂的敏感性也不同。
Mol Biochem Parasitol. 2001 Apr 25;114(1):41-52. doi: 10.1016/s0166-6851(01)00236-5.
10
Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis.克氏锥虫主要半胱氨酸蛋白酶克氏锥虫蛋白酶的过表达与增强的循环后期发育相关。
Eur J Biochem. 1997 Mar 1;244(2):596-603. doi: 10.1111/j.1432-1033.1997.t01-1-00596.x.

引用本文的文献

1
Nifuroxazide and 4-Hydroxybenzhydrazone Derivatives as New Antiparasitic ( and ) and Anti- Agents.硝呋齐特和4-羟基苯腙衍生物作为新型抗寄生虫和抗菌剂。
Pharmaceutics. 2025 May 7;17(5):621. doi: 10.3390/pharmaceutics17050621.
2
Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.靶向半胱氨酸蛋白酶及其抑制剂以对抗锥虫病。
Curr Med Chem. 2024;31(16):2135-2169. doi: 10.2174/0929867330666230619160509.
3
Oxidative stress implications for therapeutic vaccine development against Chagas disease.氧化应激对治疗性疫苗防治恰加斯病的影响。
Expert Rev Vaccines. 2021 Nov;20(11):1395-1406. doi: 10.1080/14760584.2021.1969230. Epub 2021 Aug 30.
4
Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against .克氏锥虫 cruzipain 及其生理抑制剂 chagasin 作为一种基于 DNA 的治疗性疫苗对抗.
Front Immunol. 2020 Oct 9;11:565142. doi: 10.3389/fimmu.2020.565142. eCollection 2020.
5
Challenges in Chagas Disease Drug Development.**标题**:**开发治疗恰加斯病药物所面临的挑战** **正文**:恰加斯病是一种由克氏锥虫引起的寄生虫病,主要流行于中美洲、南美洲以及北美洲的部分地区。尽管针对这种疾病已经有一些治疗方法,但仍存在一些挑战,包括: 1. **药物疗效和安全性**:现有的治疗方法可能无法完全治愈恰加斯病,并且可能会引起一些不良反应。因此,需要开发更加有效的药物,并确保其安全性。 2. **药物研发成本**:开发一种新的药物需要大量的资金和时间,这对于一些发展中国家来说可能是一个巨大的挑战。 3. **药物可及性**:即使开发出了有效的药物,也需要确保其在全球范围内的可及性,特别是在那些恰加斯病流行的地区。 4. **疾病认知度**:恰加斯病在一些地区的认知度较低,这可能会影响药物的研发和推广。 为了克服这些挑战,需要政府、制药公司、非政府组织和学术界等各方的合作。此外,还需要加强对恰加斯病的研究,以更好地了解这种疾病,并开发出更加有效的治疗方法。
Molecules. 2020 Jun 17;25(12):2799. doi: 10.3390/molecules25122799.
6
Induction of autophagy increases the proteolytic activity of reservosomes during metacyclogenesis.自噬的诱导在变循环过程中增加了包囊体的蛋白水解活性。
Autophagy. 2021 Feb;17(2):439-456. doi: 10.1080/15548627.2020.1720428. Epub 2020 Feb 4.
7
Structure-Based Virtual Screening and In Vitro Evaluation of New Cruzain Inhibitors.基于结构的虚拟筛选和新型克氏锥虫抑制剂的体外评价。
Int J Mol Sci. 2019 Apr 9;20(7):1742. doi: 10.3390/ijms20071742.
8
Genomic comparison of Trypanosoma conorhini and Trypanosoma rangeli to Trypanosoma cruzi strains of high and low virulence.对高毒力和低毒力的克氏锥虫与康氏锥虫和兰氏锥虫进行基因组比较。
BMC Genomics. 2018 Oct 24;19(1):770. doi: 10.1186/s12864-018-5112-0.
9
The diverse roles of cysteine proteases in parasites and their suitability as drug targets.半胱氨酸蛋白酶在寄生虫中的多种作用及其作为药物靶点的适用性。
PLoS Negl Trop Dis. 2018 Aug 23;12(8):e0005639. doi: 10.1371/journal.pntd.0005639. eCollection 2018 Aug.
10
Knockout of the gamma subunit of the AP-1 adaptor complex in the human parasite Trypanosoma cruzi impairs infectivity and differentiation and prevents the maturation and targeting of the major protease cruzipain.在人类寄生虫克氏锥虫中敲除衔接蛋白复合体AP-1的γ亚基会损害其感染性和分化能力,并阻止主要蛋白酶克氏锥虫蛋白酶的成熟和靶向作用。
PLoS One. 2017 Jul 31;12(7):e0179615. doi: 10.1371/journal.pone.0179615. eCollection 2017.